LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
about
Parkinson's disease: from monogenic forms to genetic susceptibility factorsGenetics of Parkinson's disease - a clinical perspectiveGenetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceGenetic susceptibility in Parkinson's diseaseLeucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.LRRK2: cause, risk, and mechanism.Parkinson's disease in China.LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.Clinical Heterogeneity Among Variants in Parkinson's Disease: A Meta-Analysis
P2860
Q22242870-489FCA0D-AC31-421B-869E-1F3638744177Q27022109-CDA4EC2B-84DB-415F-A2F9-7578DDA3A2B3Q28077356-C74C698A-056B-4DA5-AB55-CBF692EBA284Q30435626-ABA6E3F8-533B-479C-9DF5-055A9B283FF9Q37225356-BC1F0A1D-688E-42A0-9A1D-E4E0F2694E54Q37635000-E71AC7F3-FAD6-4CA4-B194-64563838C3E7Q37822695-8516B8BC-F8F0-4498-B896-42B10A090B02Q46098287-BD35EDF9-2008-4547-9440-69AFD5AD91C8Q54571312-C7D3DC08-68BF-4C31-B406-568DC3FE0E2DQ57072461-5AC9C4B5-C66F-4A3B-A4E2-B52114E3F878
P2860
LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@ast
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@en
type
label
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@ast
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@en
altLabel
LRRK2 Gly2385Arg mutation and ...... ompared to late-onset patients
@en
prefLabel
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@ast
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@en
P50
P1476
LRRK2 Gly2385Arg mutation and ...... mpared to late-onset patients.
@en
P2888
P304
P356
10.1007/S00702-008-0065-0
P4011
b500c2dbb89722bbd086729f1b20affee47f0421
P407
P577
2008-06-04T00:00:00Z